r.kimani
Submits third-party assay reports on material purchased directly. Based in Oulu.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.37%
n=8
Suppliers covered
8
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043443 | BPC-157 | BCH | BCH-2603-G4350 | Janoshik | 2026-Q3 | 99.36 | 4.85 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041908 | Ipamorelin | SinoPep | SNP-2606-L4478 | Janoshik | 2026-Q3 | 99.47 | 5.42 | 95.3 | Supplier-supplied | 0 | PASS |
| AX-2026-042169 | Melanotan II | JEEP | JEEP-2604-R9103 | Janoshik | 2026-Q2 | 99.43 | 5.22 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041286 | Semaglutide | WWB | WWB-2603-N3120 | VendorInvestigate | 2026-Q2 | 98.37 | 6.65 | 94.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019933 | Semaglutide | HJ | HJ-2507-Y6433 | PeptideMeter | 2025-Q3 | 98.39 | 3.13 | 90.0 | Buyer-sourced | 0 | PASS |
| AX-2025-020903 | MK-677 (Ibutamoren mesylate) | WXT | WXT-2502-F2050 | Janoshik | 2025-Q1 | 99.62 | 4.12 | 100.8 | Buyer-sourced | 0 | FAIL |
| AX-2024-005347 | Tirzepatide | SIG | SIG-2404-6658 | Janoshik | 2024-Q3 | 97.52 | 7.74 | 101.6 | Buyer-sourced | 0 | PASS |
| AX-2024-004887 | GHRP-6 | ERP | ERP-2408-R9378 | Medutest | 2024-Q3 | 99.37 | 4.81 | — | Supplier-supplied | 1 | MARGINAL |